Notably, G6PD, FASN and LPIN1 are upregulated in HCC compared with non-tumor livers in both HCC cohorts (Supplementary Table 9) while ETFDH is downregulated (Fig. S7D), highlighting the likely role of lipid metabolism and PPP pathways in liver cancer. Here, ETFDH is linked to hepatocellular carcinoma.